Sunshine Biopharma (SBFM) Cost of Revenue (2018 - 2026)
Sunshine Biopharma's (SBFM) quarterly Cost of Revenue came in at $250223.0 in Q1 2026, down 37.19% YoY from $398361.0 in Q1 2025, and down 95.49% on a QoQ basis from $5.5 million in Q4 2025.
Sunshine Biopharma (SBFM) Cost of Revenue (2018 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 9 years of Cost of Revenue data on file, last reported at $250223.0 in Q1 2026.
- Quarterly Cost of Revenue fell 37.19% year-over-year to $250223.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.0 million (up 175.96% YoY) and the FY2025 annual result came in at $24.1 million, up 2457.78% from the prior year.
- Cost of Revenue declined to $250223.0 in Q1 2026, from $5.5 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $6.0 million in Q2 2025 to a low of -$16.8 million in Q4 2024.
- A 5-year average of $180320.5 and a median of $241897.0 in 2023 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2023 — Cost of Revenue surged 4015.1% — and 2024, when it sank 7348.2%.
- Tracing SBFM's Cost of Revenue over 5 years: stood at $2.2 million in 2022, then tumbled by 89.72% to $231261.0 in 2023, then slumped by 7348.2% to -$16.8 million in 2024, then jumped by 133.1% to $5.5 million in 2025, then slumped by 95.49% to $250223.0 in 2026.
- The last three Cost of Revenue figures came in at $250223.0 (Q1 2026), $5.5 million (Q4 2025), and $235217.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Sunshine Biopharma | 1.53 Mn | -12.22 Mn | 2.43 Mn | 6.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.84 Mn |
| Jun 30, 2026 | 6.84 Mn |
| Mar 31, 2026 | 250,223.00 |
| Mar 31, 2026 | 250,223.00 |
| Dec 31, 2025 | 5.55 Mn |
| Dec 31, 2025 | 5.55 Mn |
| Sep 30, 2025 | 235,217.00 |
| Sep 30, 2025 | 235,217.00 |
| Jun 30, 2025 | 5.99 Mn |
| Jun 30, 2025 | 5.99 Mn |
| Mar 31, 2025 | 398,361.00 |
| Mar 31, 2025 | 398,361.00 |
| Dec 31, 2024 | -16.76 Mn |
| Dec 31, 2024 | -16.76 Mn |
| Sep 30, 2024 | 282,745.00 |
| Sep 30, 2024 | 282,745.00 |
| Jun 30, 2024 | 256,325.00 |
| Jun 30, 2024 | 256,325.00 |
| Mar 31, 2024 | 198,046.00 |
| Mar 31, 2024 | 198,046.00 |